2023年
Matsunuma M, Kan R, Yamada Y, Hamada K, Kanagawa M, Nomizu M, Kikkawa Y.
Chain-specificity of laminin α1-5 LG45 modules in the recognition of carbohydrate-linked
receptors and intramolecular binding.
Sci Rep. 2023 Jun 27;13(1):10430. doi: 10.1038/s41598-023-37533-y.
2022年
Kikkawa Y, Matsunuma M, Kan R, Yamada Y, Hamada K, Nomizu M, Negishi Y,
Nagamori S, Toda T, Tanaka M, Kanagawa M.
Laminin α5_CD239_Spectrin is a candidate association that compensates the
linkage between the basement membrane and cytoskeleton in skeletal muscle
fibers.
Matrix Biology Plus. 2022: 15, 100118.
https://doi.org/10.1016/j.mbplus.2022.100118.
Tokuoka H, Imae R, Nakashima H, Manya H, Masuda C, Hoshino S, Kobayashi
K, Lefeber DJ, Matsumoto R, Okada T, Endo T,
Kanagawa M, Toda T.
CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy
mouse model.
Nat Commun. 2022, 13(1):1847. doi: 10.1038/s41467-022-29473-4.
Ikenaga C, Date H,Kanagawa M, Mitsui J, Ishiura H, Yoshimura J, Pinal-Fernandez I, Mammen AL, Lloyd
TE, Tsuji S, Shimizu J, Toda T, Goto J.
Muscle transcriptomics shows overexpression of cadherin 1 in inclusion
body myositis.
Ann Neurol. 2022 Jan 22. doi: 10.1002/ana.26304.
2021年
Kanagawa M. Dystroglycanopathy: From Elucidation of Molecular and Pathological Mechanisms to Development
of Treatment Methods. Int. J. Mol. Sci. 22(23), 13162. 2021
Bai HY, Min LJ, Shan BS, Iwanami J, Kan-No H, Kanagawa M, Mogi M, Horiuchi M. Angiotensin II and Amyloid-β Synergistically Induce Brain Vascular Smooth
Muscle Cell Senescence.Am J Hypertens. 34(5):552-562. 2021.
2020年
Furukawa JI, Hanamatsu H, Nishikaze T, Manya H, Miura N, Yagi H, Yokota
I, Akasaka-Manya K, Endo T, Kanagawa M, Iwasaki N, Tanaka K. Lactone-Driven Ester-to-Amide Derivatization for Sialic Acid Linkage-Specific
Alkylamidation. Anal Chem. 92(21):14383-14392. 2020.
Morioka S, Sakaguchi H, Mohri H, Taniguchi-Ikeda M, Kanagawa M, Suzuki T, Miyagoe-Suzuki Y, Toda T, Saito N, Ueyama T. Congenital hearing impairment associated with peripheral cochlear nerve
dysmyelination in glycosylation-deficient muscular dystrophy. PLoS Genet. 16(5):e1008826. 2020.
Min LJ, Iwanami J, Shudou M, Bai HY, Shan BS, Higaki A, Mogi M, Horiuchi M. Deterioration of cognitive function after transient cerebral ischemia with
amyloid-β infusion-possible amelioration of cognitive function by AT2 receptor
activation. J Neuroinflammation. 17(1):106. 2020.
Seki T, Kanagawa M, Kobayashi K, Kowa H, Yahata N, Maruyama K, Iwata N, Inoue H, Toda T.
Galectin 3-binding protein suppresses amyloid-β production by modulating
β-cleavage of amyloid precursor protein. J Biol Chem. 13;295(11): 3678-3691. 2020.
Kuwabara N, Imae R, Manya H, Tanaka T, Mizuno M, Tsumoto H, Kanagawa M, Kobayashi K, Toda T, Senda T, Endo T, Kato R. Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate
transferase related to muscular dystrophy.
Nat Commun. 11(1):303. 2020.
2019年
Ujihara Y, Kanagawa M, Mohri S, Takatsu S, Kobayashi K, Toda T, Naruse K, Katanosaka Y. Elimination of fukutin reveals cellular and molecular pathomechanisms in
muscular dystrophy-associated heart failure. Nat Commun. 10(1):5754. 2019.
Sugawara Y, Hamada K, Yamada Y, Kumai J, Kanagawa M, Kobayashi K, Toda T, Negishi Y, Katagiri F, Hozumi K, Nomizu M, Kikkawa
Y. Characterization of dystroglycan binding in adhesion of human induced pluripotent
stem cells to laminin-511 E8 fragment. Sci Rep. 9(1):13037. 2019.
Sekiya H, Kowa H, Koga H, Takata M, Satake W, Futamura N, Funakawa I, Jinnai
K, Takahashi M, Kondo T, Ueno Y, Kanagawa M, Kobayashi K, Toda T. Wide distribution of alpha-synuclein oligomers in multiple system atrophy
brain detected by proximity ligation. Acta Neuropathol. 137(3):455-466. 2019.
Kukida M, Mogi M, Kan-No H, Tsukuda K, Bai HY, Shan BS, Yamauchi T, Higaki
A, Min LJ, Iwanami J, Okura T, Higaki J, Horiuchi M.
AT2 receptor stimulation inhibits phosphate-induced vascular calcification. Kidney Int. 95(1):138-148. 2019.
2018年
Uenaka T, Satake W, Cha PC, Hayakawa H, Baba K, Jiang S, Kobayashi K, Kanagawa M, Okada Y, Mochizuki H, Toda T. In silico drug screening by using genome-wide association study data repurposed
dabrafenib, an anti-melanoma drug, for Parkinson's disease. Hum Mol Genet. 27(22):3974-3985. 2018.
Orlandi C, Omori Y, Wang Y, Cao Y, Ueno A, Roux MJ, Condomitti G, de Wit
J, Kanagawa M, Furukawa T, Martemyanov KA. Transsynaptic Binding of Orphan Receptor GPR179 to Dystroglycan-Pikachurin
Complex Is Essential for the Synaptic Organization of Photoreceptors. Cell Rep. 25(1):130-145.e5. 2018.
Imae R, Manya H, Tsumoto H, Osumi K, Tanaka T, Mizuno M, Kanagawa M, Kobayashi K, Toda T, Endo T. CDP-glycerol inhibits the synthesis of the functional O-mannosyl glycan
of α-dystroglycan. J Biol Chem. 293(31):12186-12198. 2018.
Tsuchiya M, Hara Y, Okuda M, Itoh K, Nishioka R, Shiomi A, Nagao K, Mori
M, Mori Y, Ikenouchi J, Suzuki R, Tanaka M, Ohwada T, Aoki J, Kanagawa M, Toda T, Nagata Y, Matsuda R, Takayama Y, Tominaga M, Umeda M. Cell surface flip-flop of phosphatidylserine is critical for PIEZO1-mediated
myotube formation. Nat Commun. 9(1):2049. 2018.
Sudo A, Kanagawa M, Kondo M, Ito C, Kobayashi K, Endo M, Minami Y, Aiba A, Toda T. Temporal requirement of dystroglycan glycosylation during brain development
and rescue of severe cortical dysplasia via gene delivery in the fetal
stage. Hum Mol Genet. 27(7):1174-1185. 2018.
Nishihara R, Kobayashi K, Imae R, Tsumoto H, Manya H, Mizuno M, Kanagawa M, Endo T, Toda T. Cell endogenous activities of fukutin and FKRP coexist with the ribitol
xylosyltransferase, TMEM5. Biochem Biophys Res Commun. 497(4):1025-1030. 2018.
Mogi M, Iwanami J, Wang XL, Tsukuda K, Kan-No H, Bai HY, Shan BS, Higaki A, Min LJ, Horiuchi M. Deletion of interferon- regulatory factor-1 results in cognitive impairment. Hypertens Res. 41(10):809-816. 2018.
Shan BS, Mogi M, Iwanami J, Bai HY, Kan-No H, Higaki A, Min LJ, Horiuchi M. Attenuation of stroke damage by angiotensin II type 2 receptor stimulation
via peroxisome proliferator-activated receptor-gamma activation.Hypertens Res. 41(10): 839-848. 2018.
Higaki A, Mogi M, Iwanami J, Min LJ, Bai HY, Shan BS, Kan-No H, Ikeda S, Higaki J, Horiuchi M. Recognition of early stage thigmotaxis in Morris water maze test with convolutional
neural network.PLoS One. 13(5):e0197003. 2018.
Yamauchi T, Mogi M, Kan-No H, Shan BS, Higaki A, Min LJ, Higaki T, Iwanami J, Ishii EI, Horiuchi M. Roles of angiotensin II type 2 receptor in mice with fetal growth restriction. Hypertens Res. 41(3):157-164. 2018.
Higaki A, Mogi M,Iwanami J, Min LJ, Bai HY, Shan BS, Kukida M, Yamauchi T, Tsukuda K, Kan-No H, Ikeda S,
Higaki J, Horiuchi M. Beneficial Effect of Mas Receptor Deficiency on Vascular Cognitive Impairment
in the Presence of Angiotensin II Type 2 Receptor.J Am Heart Assoc. 7(3):e008121. 2018.
Higaki A, Mogi M,Iwanami J, Min LJ, Bai HY, Shan BS, Kukida M, Kan-No H, Ikeda S, Higaki J, Horiuchi M. Predicting outcome of Morris water maze test in vascular dementia mouse
model with deep learning.PLoS One. 13(2):e0191708. 2018.
2017年
Kamizaki K, Doi R, Hayashi M, Saji T, Kanagawa M, Toda T, Fukada SI, Ho HH, Greenberg ME, Endo M, Minami Y. The Ror1 receptor tyrosine kinase plays a critical role in regulating satellite
cell proliferation during regeneration of injured muscle.J Biol Chem. 292(38):15939-15951. 2017.
Min LJ, Kobayashi Y, Mogi M, Tsukuda K, Yamada A, Yamauchi K, Abe F, Iwanami J, Xiao JZ, Horiuchi M. Administration of bovine casein-derived peptide prevents cognitive decline
in Alzheimer disease model mice. PLoS One. 12(2):e0171515. 2017.
2016年
Manya H, Yamaguchi Y, Kanagawa M, Kobayashi K, Tajiri M, Akasaka-Manya K, Kawakami H, Mizuno M, Wada Y,
Toda T, Endo T. The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase
Required for the Functional Glycosylation of Dystroglycan. J Biol Chem. 291(47):24618-24627. 2016.
Kuwabara N, Manya H, Yamada T, Tateno H, Kanagawa M, Kobayashi K, Akasaka-Manya K, Hirose Y, Mizuno M, Ikeguchi M, Toda T,
Hirabayashi J, Senda T, Endo T, Kato R. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation
sites of α-dystroglycan.Proc Natl Acad Sci U S A. 113(33):9280-5. 2016.
Kanagawa M, Kobayashi K, Tajiri M, Manya H, Kuga A, Yamaguchi Y, Akasaka-Manya K,
Furukawa JI, Mizuno M, Kawakami H, Shinohara Y, Wada Y, Endo T, Toda T.
Identification of a Post-translational Modification with Ribitol-Phosphate
and Its Defect in Muscular Dystrophy.Cell Rep. 14(9):2209-2223. 2016.
Tsukuda K, Mogi M, Iwanami J, Kanno H, Nakaoka H, Wang XL, Bai HY, Shan BS, Kukida M, Higaki A, Yamauchi
T, Min LJ, Horiuchi M. Enhancement of Adipocyte Browning by Angiotensin II Type 1 Receptor Blockade. PLoS One. 11(12):e0167704. 2016.
Wang XL, Iwanami J, Min LJ, Tsukuda K, Nakaoka H, Bai HY, Shan BS, Kan-No H, Kukida M, Chisaka T,
Yamauchi T, Higaki A, Mogi M, Horiuchi M. Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive
function. NPJ Aging Mech Dis. 2:16024. 2016.
Nakaoka H, Mogi M, Suzuki J, Kan-No H, Min LJ, Iwanami J, Horiuchi M.Interferon regulatory factor 1 attenuates vascular remodeling; roles of
angiotensin II type 2 receptor.J Am Soc Hypertens. 10(10):811-818. 2016.
Bai HY, Mogi M, Nakaoka H, Kan-No H, Tsukuda K, Wang XL, Shan BS, Kukida
M, Yamauchi T, Higaki A, Min LJ, Iwanami J, Horiuchi M. Synergistic Inhibitory Effect of Rosuvastatin and Angiotensin II Type 2
Receptor Agonist on Vascular Remodeling. J Pharmacol Exp Ther. 358(2):352-8. 2016.
Kukida M, Mogi M, Ohshima K, Nakaoka H,Iwanami J, Kanno H, Tsukuda K, Chisaka T, Min LJ, Wang XL, Bai HY, Shan BS, Higaki A, Yamauchi T, Okura T, Higaki J, Horiuchi
M. Angiotensin II Type 2 Receptor Inhibits Vascular Intimal Proliferation
With Activation of PPARγ. Am J Hypertens. 29(6):727-36. 2016.
2015年以前の業績は作成中